Pharmaceutical Commerce - June 2025

Pharmaceutical Commerce: June 2025 Interactive Digital Edition

June 18, 2025

20

3

View the Pharmaceutical Commerce June 2025 issue in an interactive format.

The Art of Agility

June 18, 2025

20

3

The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.

DSCSA Compliance: The Time is Now

June 18, 2025

20

3

Stay updated on the Drug Supply Chain Security Act as pharma stakeholders prepare for upcoming deadlines and improved data traceability.

Conference Connect: Determining the Future of Specialty Pharmacy

June 18, 2025

20

3

The Asembia AXS25 Summit strives to explore ways to improve patient outcomes, especially for rare and complex diseases.

Bolstering Health Technology Assessment With the Help of AI

June 17, 2025

20

3

Ways to address limitations while also enhancing the decision-making process.

Changing the PAP Model

June 17, 2025

20

3

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Building Intelligent Pharma Supply Chain Management with Real-World Data

June 17, 2025

20

3

Approaches powered by RWD can clear the way for a greater focus on patient-centered care.

Policy Whiplash? 24 Hours in the Hub Still Matters More

June 16, 2025

20

3

Doubling down on patient access and support fundamentals will win out over Washington’s next move.

Raising the Alarm

June 16, 2025

20

3

Healthcare providers must enhance awareness of counterfeit medicines to protect patients, especially as online drug purchases rise.

Financial Assistance: Matching Awareness With Action

June 16, 2025

20

3

Many uninsured and underinsured individuals remain unaware of vital financial assistance programs for prescription costs, highlighting a critical need for increased awareness and resources.

Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the Bubble

June 13, 2025

20

3

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers played their part.

Reviewing the Most-Favored Nation Model

June 13, 2025

20

3

How practical is this form of pricing in the pharma setting?

How the Rise in Self-Injectables Is Impacting Pharmaceutical Manufacturing

May 06, 2025

20

3

As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders become more prevalent, self-injectables are here to stay.

Innovation with GenAI: Lessons from Life Sciences and Beyond

April 18, 2025

20

3

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Building Agility and Adaptability Into Pharma Operations

March 17, 2025

20

3

Why driving results from such strategies—amid industry disruption—will be critical to success.

The Biosimilars Landscape Through the Eyes of an Economist

February 21, 2025

20

3

James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.